Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 5 studies | 30% ± 16% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 98% | 2741.54 | 177 / 180 | 100% | 231.97 | 430 / 430 |
intestine | 99% | 6899.28 | 954 / 966 | 97% | 60.29 | 513 / 527 |
uterus | 96% | 3170.04 | 163 / 170 | 99% | 84.52 | 456 / 459 |
lung | 97% | 2136.56 | 558 / 578 | 98% | 57.53 | 1128 / 1155 |
bladder | 95% | 4760.71 | 20 / 21 | 95% | 53.79 | 479 / 504 |
esophagus | 92% | 5807.70 | 1326 / 1445 | 98% | 57.71 | 180 / 183 |
prostate | 97% | 3223.11 | 237 / 245 | 89% | 25.45 | 445 / 502 |
brain | 67% | 1160.63 | 1762 / 2642 | 99% | 45.83 | 697 / 705 |
kidney | 88% | 1562.83 | 78 / 89 | 77% | 19.28 | 691 / 901 |
stomach | 66% | 1836.98 | 236 / 359 | 98% | 62.31 | 281 / 286 |
breast | 67% | 1183.35 | 308 / 459 | 94% | 43.16 | 1049 / 1118 |
thymus | 49% | 683.09 | 318 / 653 | 92% | 38.03 | 557 / 605 |
skin | 25% | 327.15 | 461 / 1809 | 95% | 40.55 | 447 / 472 |
pancreas | 20% | 270.26 | 66 / 328 | 90% | 36.18 | 161 / 178 |
liver | 41% | 592.88 | 92 / 226 | 65% | 18.66 | 265 / 406 |
lymph node | 0% | 0 | 0 / 0 | 100% | 291.48 | 29 / 29 |
muscle | 100% | 11404.46 | 803 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 100% | 15906.23 | 929 / 929 | 0% | 0 | 0 / 0 |
spleen | 100% | 6824.60 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 69.09 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 36.09 | 1 / 1 |
eye | 0% | 0 | 0 / 0 | 98% | 38.01 | 78 / 80 |
heart | 97% | 4810.90 | 836 / 861 | 0% | 0 | 0 / 0 |
adrenal gland | 60% | 813.24 | 155 / 258 | 33% | 12.18 | 76 / 230 |
blood vessel | 90% | 1752.49 | 1206 / 1335 | 0% | 0 | 0 / 0 |
adipose | 65% | 912.23 | 778 / 1204 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0043484 | Biological process | regulation of RNA splicing |
GO_0008380 | Biological process | RNA splicing |
GO_0006397 | Biological process | mRNA processing |
GO_0030154 | Biological process | cell differentiation |
GO_0010830 | Biological process | regulation of myotube differentiation |
GO_0005829 | Cellular component | cytosol |
GO_0005634 | Cellular component | nucleus |
GO_0003730 | Molecular function | mRNA 3'-UTR binding |
GO_0005515 | Molecular function | protein binding |
GO_0003723 | Molecular function | RNA binding |
Gene name | RBM38 |
Protein name | RNA-binding protein 38 (CLL-associated antigen KW-5) (HSRNASEB) (RNA-binding motif protein 38) (RNA-binding region-containing protein 1) (ssDNA-binding protein SEB4) RNA-binding protein 38 (RNA-binding motif protein 38) RNA binding motif protein 38 |
Synonyms | SEB4 RNPC1 |
Description | FUNCTION: RNA-binding protein that specifically bind the 3'-UTR of CDKN1A transcripts, leading to maintain the stability of CDKN1A transcripts, thereby acting as a mediator of the p53/TP53 family to regulate CDKN1A. CDKN1A is a cyclin-dependent kinase inhibitor transcriptionally regulated by the p53/TP53 family to induce cell cycle arrest. Isoform 1, but not isoform 2, has the ability to induce cell cycle arrest in G1 and maintain the stability of CDKN1A transcripts induced by p53/TP53. Also acts as a mRNA splicing factor. Specifically regulates the expression of FGFR2-IIIb, an epithelial cell-specific isoform of FGFR2. Plays a role in myogenic differentiation. .; FUNCTION: (Microbial infection) Essential factor for the splicing of the pre-mRNAs of human parvovirus B19 (B19V) and for the expression of B19V 11-kDa protein, which enhances viral replication. . |
Accessions | ENST00000342690.4 ENST00000356208.10 [Q9H0Z9-1] ENST00000371219.2 ENST00000440234.6 [Q9H0Z9-2] ENST00000344785.10 F6VZ39 Q9H0Z9 A6NG75 E9PSF1 |